Since it is profoundly involved in mTOR activation, SLC1A5 exerts functions partly via mTOR signaling and thus inhibiting SLC1A5 expression could diminish the oncogenic effect of mTOR pathway in several cancer types29, 30, 31. This evidence concerns the gene SLC1A5 and cancer.